Gilead Sciences Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (477)

Latest Posts

About This Stock More About This Stock
95 Firms Going Ex-Dividend Next Week, Including Merck, Gilead Sciences And Public Storage
Article By: Timothy J. McIntosh
Saturday, June 12, 2021 11:12 AM EDT
Ex-dividend dates are important to dividend investors because one must own a stock prior to its ex-dividend date in order to be eligible to receive its next dividend. 
In this article: DLR, KO, MRK, PSA, GILD, TROW, VIAC
Read
This High-Quality, Cheap Stock Is Rated A “Buy” And Looks 10% Undervalued
Video By: Jason Fieber
Tuesday, May 18, 2021 10:29 AM EDT
Morningstar rates GILD as a 4-star stock, with a fair value estimate of $81.00. CFRA rates GILD as a 3-star “HOLD”, with a 12-month target price of $66.00.
In this video: GILD
Watch
2 Must-Own Biotech Stocks To Buy In May
Article By: StockNews
Monday, May 3, 2021 2:42 PM EDT
After a stellar rally in 2020, biotech stocks have been selling off over the past couple of months. This offers investors a buying opportunity to scoop up quality biotech stocks such as Gilead Sciences and Vertex Pharmaceuticals at cheaper prices.
In this article: GILD, VRTX Also: XBI
Read
4 Biotech Stocks To Buy For The Q2 2021
Article By: StockNews
Monday, April 5, 2021 6:45 AM EDT
The global biotechnology market is expected to expand at a CAGR of 15.8% between 2021 – 2028.
In this article: JAZZ, AMGN, GILD, QGEN
Read
Gilead Sciences Bull Flag Breakout Nearing
Article By: Gareth Soloway
Wednesday, March 31, 2021 3:00 PM EDT
Shares of Gilead Sciences have been chopping sideways over the last three months. This has formed a beautiful Gilead Sciences bull flag and sets up for a big breakout.
In this article: GILD
Read

Latest Tweets for $GILD

No tweets yet!

$GILD

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kurt Benson 3/24/2017 10:12:59 PM

I have to agree with your assessment on $GILD. Do you know anything about $VBIO? I read a promising article here about their having a major breakthrough in #Crohn's research.

www.talkmarkets.com/.../interview-with-vitality-biopharma-inc

Not a lot of info on the company though.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kirk Sheffield 3/24/2017 10:11:55 PM

I think $GILD will rebound. This isn't the only product they have in their pipeline.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Alpha Stockman 3/24/2017 10:07:45 PM

I've been rather disappointed with #Gilead myself. After reading your article, I'm planning to offload some $GILD.

Gilead Sciences Receives Canadian Approval For HIV Drug
David Reynolds 2/20/2017 10:04:11 PM

The opening up of this market for #GileadSciences should bode well for the stock $GILD.

Gilead Sciences: Cheap Growth Or Value Trap?
Karen Klein 9/13/2016 5:39:48 PM

Excellent analysis, you have effectively convinced me to change my position on #Gilead. $GILD

3 Cult Stocks To Avoid In 2015
Bruce Powers 1/26/2015 8:01:06 AM

Great article and glad to read the reasoning to consider $GILD as a safer investment short, mid and long term.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 6:09:51 PM

Sorry all, thanks for the clarification. My bad! Now that I've read it through, it all makes total sense. $GILD, $BAC, $WFM, and $VA are my plays for 2015.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 4:48:08 PM

I'd say this is a minority view, I've seen several others stating that $GILD was a stock to buy this year.

1 to 8 of 8 comments